The Australia Pressure Monitoring Market was valued at $452.4 Million in 2025 and projected to reach to $747.9 Million by 2030, representing a compound annual growth rate of 7.4%. Australia's pressure monitoring market is positioned for sustained growth over the next five years, supported by an aging population and rising chronic disease burden.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia's pressure monitoring market is valued at $452.4 million in 2025, with strong growth trajectory reaching $747.9 million by 2030, representing a 7.4% CAGR.
Australia's rapidly aging demographic is a key growth catalyst, with increasing prevalence of hypertension, cardiovascular diseases, and chronic conditions requiring continuous pressure monitoring solutions.
Australian healthcare providers are increasingly adopting remote patient monitoring technologies, driven by telehealth expansion and the need for cost-effective chronic disease management across regional and urban areas.
Australia's advanced healthcare infrastructure and government support for digital health initiatives are accelerating the integration of pressure monitoring devices in hospitals, clinics, and home care settings.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | WEARABLE BLOOD PRESSURE MONITORS (Technology) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8.3% from 2025 to 2030 |
| Largest Segment | DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 14.58 (2025) |
| Revenue Forecast (Billions) | ~USD 21.72 (2030) |
| Segments Covered | Product, Type, Technology, Usability, Procedure, Therapeutic Application |
6 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2029 | 2030 | 2031 | 2032 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| AMBULATORY CARE CENTERS | 98.8 | 105.4 | 112.5 | 151.4 | 164.3 | 178.7 | 194.9 | 8.2 |
| HOME CARE SETTINGS | 89.3 | 95.2 | 102.5 | 143 | 156.6 | 171.7 | 189 | 9.1 |
| HOSPITALS & CLINICS | 205.4 | 219.1 | 232 | 302.4 | 325.6 | 351.2 | 380 | 7.3 |
| OTHER END USERS | 29.8 | 31.7 | 32.7 | 38 | 39.7 | 41.6 | 43.8 | 4.3 |
| PRIMARY CENTERS | 33.5 | 35.7 | 37 | 44.3 | 46.7 | 49.4 | 52.3 | 5.1 |
| URGENT CARE CENTERS | 21.9 | 23.4 | 24.6 | 31 | 33.1 | 35.4 | 38 | 6.4 |
| TOTAL | 478.7 | 510.5 | 541.2 | 710.2 | 766 | 828 | 897.8 | 7.5 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| CONVATEC | United Kingdom | Public Company | Advanced Wound Care,Ostomy Care,Continence & Critical Care, |
| HILL-ROM HOLDINGS, INC. | United States | Private Company | Patient Support Systems (beds, surfaces, mobility, IT and software, service contracts),Front Line Care (exam, diagnostics, monitoring, cardiology, vision, respiratory health),Surgical Solutions (tables, lights, pendants, positioning devices and accessories), |
| HALMA PLC | United Kingdom | Public Company | Safety,Environmental & Analysis,Healthcare, |
| ELSTER GROUP | Germany | Private Company | Gas meters, regulators, and gas infrastructure solutions,Electricity meters and AMI communications,Water meters and related solutions, |
| OMRON CORPORATION. | Japan | Public Company | Industrial Automation (sensors, safety, motion, robotics, automation systems),Healthcare (cardiovascular, respiratory, pain management, remote monitoring),Social Systems (station systems, traffic control, payment systems), |
| DRäGERWERK AG & CO. KGAA | Germany | Public Company | Critical-care and perioperative equipment (ventilators, anaesthesia, monitoring),Neonatal and perinatal care (incubators, thermoregulation, phototherapy),Hospital infrastructure and consumables (pendants, gas pipelines, accessories), |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| BAXTER INTERNATIONAL, INC. | United States | Public Company | Medical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding), |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitoring systems and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, EP, polygraphs),Defibrillators, AEDs, and life-support (ventilators, anesthesia, pacemakers), |
| INTEGRA LIFESCIENCES CORPORATION | United States | Public Company | Codman Specialty Surgical – Neurosurgery & Neurocritical Care,Surgical Instruments, Headlamps, and Lighting,Tissue Technologies – Wound, Burn, and Surgical Reconstruction, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Interventional Cardiology & Structural Heart (incl. WATCHMAN FLX),Cardiac Rhythm Management & Electrophysiology,Endoscopy (GI & Pulmonary, incl. SpyGlass, single-use scopes), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Infusion pumps & medication safety software,Vascular access & needlefree connectors, |
| MASIMO CORPORATION | United States | Private Company | SET and Rainbow SET pulse oximetry (devices and sensors),Brain function and hemodynamic monitoring,Hospital automation and connectivity (Patient SafetyNet, Iris, iSirona, Replica, UniView), |
ConvaTec is a publicly traded United Kingdom-based company founded in 1978 that specializes in medical products and technologies for ostomy care, continence care, and wound management.
Hill-Rom Holdings, Inc. is a privately held American medical device and equipment manufacturer founded in 1915. The company employs 10,000 people and produces hospital beds, patient monitoring systems, and other healthcare solutions.
Halma PLC is a publicly traded British company founded in 1894 with 9,000 employees that manufactures safety, environmental, and infrastructure products across multiple industrial sectors.
Elster Group is a privately held German company with 6,985 employees that manufactures metering and data management solutions for utilities and industrial applications.
Omron Corporation is a publicly traded Japanese company founded in 1933 with 26,050 employees that manufactures automation, healthcare, and electronic components and systems.
Drägerwerk AG & Co. KGaA is a publicly traded German company founded in 1889 with 16,033 employees specializing in medical and safety technology products including ventilators and anesthesia systems.
Abbott is a publicly traded American healthcare company founded in 1888 with 115,000 employees that develops pharmaceuticals, diagnostics, nutritional products, and medical devices.
Baxter International, Inc. is a publicly traded American healthcare company founded in 1931 with 37,500 employees that manufactures and distributes renal care, IV therapies, and other medical products.
Terumo Corporation is a publicly traded Japanese medical device company founded in 1921 with 30,591 employees producing cardiovascular, blood management, and general hospital products.
Nihon Kohden Corporation is a publicly traded Japanese company founded in 1951 with 6,116 employees that manufactures patient monitoring systems, defibrillators, and other medical equipment.
Integra LifeSciences Corporation is a publicly traded American medical device company founded in 1989 with 4,427 employees specializing in surgical instruments, orthopedic products, and regenerative technologies.
Boston Scientific Corporation is a publicly traded American medical device company founded in 1979 with 59,000 employees manufacturing cardiovascular, endoscopy, and neuromodulation products.
ICU Medical, Inc. is a publicly traded American company founded in 1984 with 13,000 employees that designs and manufactures infusion therapy and critical care products.
Masimo Corporation is a privately held American medical technology company founded in 1989 with 2,200 employees specializing in non-invasive patient monitoring and diagnostic solutions.
Australia's pressure monitoring market was valued at $452.4 million in 2025 and is projected to grow to $747.9 million by 2030.
Australia's pressure monitoring market is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2030.
Key drivers include Australia's aging population, rising prevalence of chronic cardiovascular conditions, digital health adoption, telemedicine expansion, and strong healthcare infrastructure investment.
Wearable and connected pressure monitoring devices, remote patient monitoring solutions, and point-of-care diagnostic systems are experiencing the fastest growth in Australia.
Australia represents a significant and mature market within Asia Pacific, characterized by high healthcare spending, strong regulatory standards, and advanced digital health infrastructure supporting faster adoption of innovative monitoring technologies.
The study involved four major activities to estimate the current size of the pressure monitoring market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various sources were utilized to identify and gather information for the study of the pressure monitoring market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends, down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Extensive primary research was conducted after gathering information about the pressure monitoring market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the pressure monitoring market, as well as key opinion leaders.
Primary interviews were conducted to gather valuable insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. This primary research also provided an understanding of various trends related to technologies, applications, industry verticals, and regions. Stakeholders, including customers and end users, were interviewed to gain the buyers' perspective on suppliers, the products themselves, their current usage, and the future outlook of their businesses. This information is crucial as it impacts the overall market dynamics.
The following is a breakdown of the primary respondents:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the pressure monitoring market includes the following details.
The market sizing was undertaken from a global perspective.
Country-level Analysis: The size of the pressure monitoring market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall pressure monitoring market were obtained from secondary data and validated by primary participants to arrive at the total pressure monitoring market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall pressure monitoring market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the pressure monitoring market.
Pressure monitoring refers to the global industry dedicated to developing, manufacturing, and distributing devices and systems designed to measure, monitor, and record pressure levels within the body or in clinical settings. These systems are essential for diagnosing and managing various medical conditions, including hypertension, glaucoma, respiratory disorders, and cardiovascular diseases. The market is driven by technological advancements, an aging population, the increasing prevalence of chronic diseases, and the growing adoption of remote patient monitoring and wearable health devices.
Full forecast, segment splits, and company analysis for all Pressure Monitoring Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report